TY - JOUR
T1 - Alfentanil-induced hypermetabolism, seizure, and histopathology in rat brain
AU - Kofke, W. A.
AU - Garman, R. H.
AU - Tom, W. C.
AU - Rose, M. E.
AU - Hawkins, R. A.
PY - 1992
Y1 - 1992
N2 - We evaluated the effect of alfentanil on hippocampal glucose utilization and histopathology associated with alfentanil-induced seizures. Three separate experiments were performed. First, anesthetized, paralyzed Long-Evans rats (n = 15; 5 rats per group) were mechanically ventilated and randomly assigned to three groups: (a) control, 70% N2O and 30% O2 continued for 1h; (b) low-dose alfentanil (150 μg/kg IV bolus), followed by infusion at 15 μg·kg-1·min-1 for 1 h without N2O; or (c) high-dose alfentanil (1000 μg/kg IV bolus), followed by infusion at 100 μg·kg-1·min-1 for 1 h without N2O. After 1 h, [6-14C]glucose was injected intravenously for autoradiography. With high-dose alfentanil, there was increased glucose utilization in the ventral hippocampus and the lateral septal nucleus. In the second experiment, anesthetized, paralyzed Sprague Dawley rats (n = 12; 4 rats per group) were mechanically ventilated, underwent insertion of hippocampal depth electrodes, and were randomly assigned to three groups: (a) control, 70% N2O and 30% O2; (b) low-dose alfentanil (150 μg/kg IV bolus), with 70% N2O and 30% O2; or (c) high-dose alfentanil (1000 μg/kg IV bolus), with 70% N2O and 30% O2. An epileptiform pattern was observed on hippocampal and subdermal electroencephalographic recordings in both alfentanil groups. In the third experiment, anesthetized, paralyzed Sprague-Dawley rats (n = 20) were mechanically ventilated and assigned to two groups: (a) control, 70% N2O and 30% O2 (n = 5) or 100% O2 (n = 5) continued for 1 h; or (b) alfentanil (2000 μg/kg IV bolus), followed by infusion at 33.3 μg·kg-1·min-1 for 1 h with 100% O2. After tracheal extubation, the rats recovered overnight. Light-microscopic evaluation revealed hippocampal or amygdaloid damage in 6 of the 10 alfentaniltreated rats. High doses of alfentanil administered to rats can produce limbic system seizure activity with hypermetabolism associated with neuropathologic lesions.
AB - We evaluated the effect of alfentanil on hippocampal glucose utilization and histopathology associated with alfentanil-induced seizures. Three separate experiments were performed. First, anesthetized, paralyzed Long-Evans rats (n = 15; 5 rats per group) were mechanically ventilated and randomly assigned to three groups: (a) control, 70% N2O and 30% O2 continued for 1h; (b) low-dose alfentanil (150 μg/kg IV bolus), followed by infusion at 15 μg·kg-1·min-1 for 1 h without N2O; or (c) high-dose alfentanil (1000 μg/kg IV bolus), followed by infusion at 100 μg·kg-1·min-1 for 1 h without N2O. After 1 h, [6-14C]glucose was injected intravenously for autoradiography. With high-dose alfentanil, there was increased glucose utilization in the ventral hippocampus and the lateral septal nucleus. In the second experiment, anesthetized, paralyzed Sprague Dawley rats (n = 12; 4 rats per group) were mechanically ventilated, underwent insertion of hippocampal depth electrodes, and were randomly assigned to three groups: (a) control, 70% N2O and 30% O2; (b) low-dose alfentanil (150 μg/kg IV bolus), with 70% N2O and 30% O2; or (c) high-dose alfentanil (1000 μg/kg IV bolus), with 70% N2O and 30% O2. An epileptiform pattern was observed on hippocampal and subdermal electroencephalographic recordings in both alfentanil groups. In the third experiment, anesthetized, paralyzed Sprague-Dawley rats (n = 20) were mechanically ventilated and assigned to two groups: (a) control, 70% N2O and 30% O2 (n = 5) or 100% O2 (n = 5) continued for 1 h; or (b) alfentanil (2000 μg/kg IV bolus), followed by infusion at 33.3 μg·kg-1·min-1 for 1 h with 100% O2. After tracheal extubation, the rats recovered overnight. Light-microscopic evaluation revealed hippocampal or amygdaloid damage in 6 of the 10 alfentaniltreated rats. High doses of alfentanil administered to rats can produce limbic system seizure activity with hypermetabolism associated with neuropathologic lesions.
UR - http://www.scopus.com/inward/record.url?scp=0026485317&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026485317&partnerID=8YFLogxK
U2 - 10.1213/00000539-199212000-00014
DO - 10.1213/00000539-199212000-00014
M3 - Article
C2 - 1443714
AN - SCOPUS:0026485317
SN - 0003-2999
VL - 75
SP - 953
EP - 964
JO - Anesthesia and Analgesia
JF - Anesthesia and Analgesia
IS - 6
ER -